152 related articles for article (PubMed ID: 26541255)
1. In reply--Risk of Disseminated Varicella Zoster in Immunosuppressed Patients Receiving Zoster Vaccination.
Cheetham TC; Sy LS; Jacobsen SJ
Mayo Clin Proc; 2015 Nov; 90(11):1586-7. PubMed ID: 26541255
[No Abstract] [Full Text] [Related]
2. Risk of Disseminated Varicella Zoster in Immunosuppressed Patients Receiving Zoster Vaccination.
Bubb MR
Mayo Clin Proc; 2015 Nov; 90(11):1585-6. PubMed ID: 26541254
[No Abstract] [Full Text] [Related]
3. Risk of Herpes Zoster and Disseminated Varicella Zoster in Patients Taking Immunosuppressant Drugs at the Time of Zoster Vaccination.
Cheetham TC; Marcy SM; Tseng HF; Sy LS; Liu IL; Bixler F; Baxter R; Donahue JG; Naleway AL; Jacobsen SJ
Mayo Clin Proc; 2015 Jul; 90(7):865-73. PubMed ID: 26051268
[TBL] [Abstract][Full Text] [Related]
4. [The clinical and epidemic characteristics of shingles (herpes zoster) and its prevention with vaccines].
Afonina NM; Mikheeva IV
Ter Arkh; 2013; 85(11):130-3. PubMed ID: 24432613
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Live Attenuated Herpes Zoster Vaccine in Patients With Inflammatory Bowel Diseases.
Khan N; Trivedi C; Kavani H; Medvedeva E; Lewis J; Yang YX
Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1341-1347. PubMed ID: 30326303
[TBL] [Abstract][Full Text] [Related]
6. Varicella-zoster virus vaccination under the exogenous boosting hypothesis: two ethical perspectives.
Luyten J; Ogunjimi B; Beutels P
Vaccine; 2014 Dec; 32(52):7175-8. PubMed ID: 25454883
[TBL] [Abstract][Full Text] [Related]
7. The need for better preventative strategies for inflammatory bowel disease patients at risk of herpes zoster virus.
Bye WA; Sparrow MP; Connor SJ; Andrews JM; Ellard K; Ng W; Hume G; Antoniades S; Walsh AJ
Intern Med J; 2017 Nov; 47(11):1263-1269. PubMed ID: 28516725
[TBL] [Abstract][Full Text] [Related]
8. In Reply I-Risk of Disseminated Disease in Immunosuppressed Patients Receiving Live Zoster Vaccine.
Bubb MR
Mayo Clin Proc; 2016 Jul; 91(7):971. PubMed ID: 27378041
[No Abstract] [Full Text] [Related]
9. Evaluation of the acceptability of a vaccine against herpes zoster in the over 50 years old: an Italian observational study.
Valente N; Lupi S; Stefanati A; Cova M; Sulcaj N; Piccinni L; ; Gabutti G
BMJ Open; 2016 Oct; 6(10):e011539. PubMed ID: 27797989
[TBL] [Abstract][Full Text] [Related]
10. Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway.
Marchetti S; Guzzetta G; Flem E; Mirinaviciute G; Scalia Tomba G; Manfredi P
Vaccine; 2018 Feb; 36(8):1116-1125. PubMed ID: 29366704
[TBL] [Abstract][Full Text] [Related]
11. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H
Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115
[TBL] [Abstract][Full Text] [Related]
12. Risk of Disseminated Disease in Immunosuppressed Patients Receiving Live Zoster Vaccine.
Young EJ
Mayo Clin Proc; 2016 Jul; 91(7):971. PubMed ID: 27378040
[No Abstract] [Full Text] [Related]
13. Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine.
Tseng HF; Lewin B; Hales CM; Sy LS; Harpaz R; Bialek S; Luo Y; Jacobsen SJ; Reddy K; Huang PY; Zhang J; Anand S; Bauer EM; Chang J; Tartof SY
J Infect Dis; 2015 Oct; 212(8):1222-31. PubMed ID: 26038400
[TBL] [Abstract][Full Text] [Related]
14. [How I prevent...herpes zoster by vaccination].
Nikkels AF; Piérard GE
Rev Med Liege; 2007 Jan; 62(1):44-7. PubMed ID: 17343129
[TBL] [Abstract][Full Text] [Related]
15. Varicella vaccination in the immunocompromised.
Malaiya R; Patel S; Snowden N; Leventis P
Rheumatology (Oxford); 2015 Apr; 54(4):567-9. PubMed ID: 24758889
[No Abstract] [Full Text] [Related]
16. Zostavax : a subcutaneous vaccine for the prevention of herpes zoster.
Doan HQ; Ung B; Ramirez-Fort MK; Khan F; Tyring SK
Expert Opin Biol Ther; 2013 Oct; 13(10):1467-77. PubMed ID: 23984934
[TBL] [Abstract][Full Text] [Related]
17. Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study.
Horn J; Damm O; Greiner W; Hengel H; Kretzschmar ME; Siedler A; Ultsch B; Weidemann F; Wichmann O; Karch A; Mikolajczyk RT
BMC Med; 2018 Jan; 16(1):3. PubMed ID: 29316913
[TBL] [Abstract][Full Text] [Related]
18. Zoster vaccine in older adults.
Fried R
J Am Geriatr Soc; 2010 Sep; 58(9):1799-800. PubMed ID: 20863342
[No Abstract] [Full Text] [Related]
19. Modelling the impact of varicella vaccination on varicella and zoster.
Karhunen M; Leino T; Salo H; Davidkin I; Kilpi T; Auranen K
Epidemiol Infect; 2010 Apr; 138(4):469-81. PubMed ID: 19796447
[TBL] [Abstract][Full Text] [Related]
20. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
